Literature DB >> 13009470

Retrolental fibroplasia; blindness in infants of low weight at birth.

A APPELBAUM.   

Abstract

Retrolental fibroplasia is today the principal cause of blindness in children of preschool age, exceeding all other causes combined. The disease occurs in infants of low weight at birth, commonly those born prematurely. The incidence of the disease is rising at an alarming rate. Vitamin E deficiency, corticotropin (ACTH) deficiency, the use of cow's milk in place of mother's milk, and improper oxygenation have been suggested as etiologic factors but the cause remains a mystery. Often the incidence is high in institutions in which maximal care is given premature infants.Clinically, the disease advances through an "active" phase during which regression is possible, and a "subsiding" or "cicatricial" phase which terminates with the formation of a disorganized opaque mass behind the lens. The earliest manifestations are noted in the fundi. Hemorrhages, neovascularization, transudation commencing in the periphery, and retinal separation contribute to the formation of the characteristic retrolental membrane. The diagnosis may be made when the retrolental membrane is observed in the eye of an infant whose weight at birth was low. Differential diagnosis is required occasionally. Thus far, no form of therapy has prevented or reversed the pathologic changes successfully. Use of vitamin E, corticotropin and mother's milk has not influenced the incidence of the disease. Avoidance of premature delivery if possible is indicated.

Entities:  

Keywords:  RETROLENTAL FIBROPLASIA

Mesh:

Substances:

Year:  1952        PMID: 13009470      PMCID: PMC1521441     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  8 in total

1.  Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach.

Authors:  K CAMPBELL
Journal:  Med J Aust       Date:  1951-07-14       Impact factor: 7.738

2.  Retrolental fibroplasia; etiology and prophylaxis.

Authors:  T S SZEWCZYK
Journal:  Am J Ophthalmol       Date:  1952-03       Impact factor: 5.258

3.  Retrolental fibroplasia and anoxia.

Authors:  C J RUDOLPH; E M SIRLIN
Journal:  J Indiana State Med Assoc       Date:  1951-12

4.  Retrolental fibroplasia; a clinicopathologic study.

Authors:  H RYAN
Journal:  Am J Ophthalmol       Date:  1952-03       Impact factor: 5.258

5.  Retrolental fibroplasia: etiology and prophylaxis; a preliminary report.

Authors:  T S SZEWCZYK
Journal:  Am J Ophthalmol       Date:  1951-12       Impact factor: 5.258

6.  The responsibility of the obstetrician to the fetus. I. An analysis of fetal and neonatal mortality in 10,000 deliveries.

Authors:  J W SIMPSON; L J GEPPERT
Journal:  Am J Obstet Gynecol       Date:  1951-11       Impact factor: 8.661

7.  Retrolental fibroplasia.

Authors:  A B REESE; F C BLODI
Journal:  Am J Ophthalmol       Date:  1951-01       Impact factor: 5.258

8.  Retrolental fibroplasia in premature infants; studies on the prophylaxis of the disease; the use of alpha tocopheryl acetate.

Authors:  W C OWENS; E U OWENS
Journal:  Am J Ophthalmol       Date:  1949-12       Impact factor: 5.258

  8 in total
  2 in total

1.  Non-invasive determination of murine placental and foetal functional parameters with multispectral optoacoustic tomography.

Authors:  Kausik Basak; Xosé Luís Deán-Ben; Sven Gottschalk; Michael Reiss; Daniel Razansky
Journal:  Light Sci Appl       Date:  2019-08-14       Impact factor: 17.782

Review 2.  Supplemental Oxygen in the Newborn: Historical Perspective and Current Trends.

Authors:  Maxwell Mathias; Jill Chang; Marta Perez; Ola Saugstad
Journal:  Antioxidants (Basel)       Date:  2021-11-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.